Mistras opened higher at $20.20, compared with its previous close of $20.18. In the last trading session, the stock traded between $20.19 and $20.23. It showed a sideways intraday trend.
An investment of $100 made 5 years ago in Mistras is now worth
$ 223.15
Giving a profit of
$ 123.15 (123.15%)
Note: Past profits do not guarantee future returns.
Rating from 1 Analysts
Today's Change
+$0.02 (+0.07%)
Day High
$20.23
Day Low
$20.19
Day Open
$20.20
Prev Close
$20.18
Volume
1,69,368
1W Return
-0.21%
1M Return
-2.29%
3M Return
8.49%
6M Return
13.65%
1Y Return
55.35%
Market Cap ($ Mn)
644
PE Ratio
22.28
PB Ratio
2.45
PEG Ratio
0.40
ROE
7.87%
ROCE
8.50%
EPS (TTM)
$0.22
1 Week
-0.21%
1 Month
-2.29%
3 Months
8.49%
6 Months
13.65%
9 Months
41.62%
Halper Sadeh investigates MISTRAS Group sale for fair price compliance
Halper Sadeh LLC is investigating the $20.35 per share cash sale of MISTRAS Group to H.I.G. Capital affiliates. The probe examines if the board breached fiduciary duties by failing to obtain the best possible price. Insiders may receive substantial financial benefits not available to ordinary shareholders under the deal terms. The firm seeks increased consideration and additional disclosures on behalf of affected investors.
26 days agoHalper Sadeh investigates Mistras, Lifecore, Marygold shareholder deals
Halper Sadeh LLC investigates Mistras Group, Lifecore Biomedical, and Marygold Companies for potential fiduciary breaches. Mistras Group sale to H.I.G. Capital affiliates is priced at $20.35 per share in cash. Lifecore Biomedical acquisition by Webster Equity Partners offers $6.28 per share plus a contingent value right. Marygold Companies sale to Madison Dearborn Partners is set at $2.00 per share in cash.
1mo agoKahn Swick & Foti probes MISTRAS Group sale price adequacy
Kahn Swick & Foti investigates adequacy of MISTRAS Group sale to H.I.G. Capital affiliates. Shareholders set to receive $20.35 in cash per share under the proposed transaction terms. Firm assesses if the process and price undervalue the company for investors.
1mo agoSBS Law probes Mistras Group directors for fiduciary duty breaches
SBS Law investigates Mistras Group (NYSE: MG) directors for fiduciary duty breaches. Firm seeks claims from shareholders who suffered investment losses. Inquiry focuses on potential management and board misconduct. Affected investors can contact the firm via phone or email.
1mo agoMISTRAS Group agrees to $866 million acquisition by H.I.G. Capital
MISTRAS Group agreed to be acquired by H.I.G. Capital for $866 million, including debt. Shareholders will receive $20.35 per share, an 8% premium to the 30-day VWAP. The deal includes a 40-day go-shop period ending October 27, 2026. Mistras recently beat Q2FY26 EPS estimates and raised FY26 revenue guidance. Stock hit a 52-week high following the announcement.
1mo agoHalper Sadeh LLC probes MISTRAS Group sale to H.I.G. Capital at $20.35
Halper Sadeh LLC investigates MISTRAS Group sale to H.I.G. Capital for $20.35 per share. Firm alleges insiders may receive benefits not available to ordinary shareholders. Investigation covers potential breaches of fiduciary duty and fair sales process. Shareholders can contact the firm on a contingent fee basis with no upfront costs.
1mo ago| Stock | LTP | Change % | Market Cap | PE |
|---|---|---|---|---|
| $227.26 | +0.88% | $90,239.26M | 41.58 | |
| $1,150.80 | +4.15% | $71,254.08M | 24.77 | |
| $40.10 | +0.48% | $69,776.73M | 21.82 | |
| $108.83 | +0.39% | $47,173.34M | 27.91 | |
| $32.17 | -0.40% | $29,801.58M | 20.49 | |
| $177.01 | +0.66% | $27,335.65M | 7.23 | |
| $100.23 | -1.34% | $26,524.47M | 43.11 | |
| $205.98 | +0.96% | $26,424.35M | 29.47 | |
| $188.41 | +0.10% | $22,047.17M | 34.22 | |
| $95.67 | -0.50% | $17,344.97M | 37.09 | |
| $191.09 | +0.84% | $16,112.90M | 20.64 | |
| $53.79 | -0.79% | $14,180.39M | 40.69 |
An investment of $100 made 5 years ago in Mistras is now worth
$ 223.15
Giving a profit of
$ 123.15 (123.15%)
Note: Past profits do not guarantee future returns.
